Dmitri Debabov

1.9k total citations
42 papers, 1.5k citations indexed

About

Dmitri Debabov is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Dmitri Debabov has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Infectious Diseases and 10 papers in Molecular Medicine. Recurrent topics in Dmitri Debabov's work include Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Amino Acid Enzymes and Metabolism (5 papers). Dmitri Debabov is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotic Resistance in Bacteria (10 papers) and Amino Acid Enzymes and Metabolism (5 papers). Dmitri Debabov collaborates with scholars based in United States, Austria and Spain. Dmitri Debabov's co-authors include Francis C. Neuhaus, Michael Y. Kiriukhin, Kevin M. Krause, Bret M. Benton, Markus Nagl, Koné Kaniga, Deborah L. Higgins, Waldemar Gottardi, Michael P. Heaton and John Pace and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemistry.

In The Last Decade

Dmitri Debabov

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitri Debabov United States 19 620 559 300 227 217 42 1.5k
John Pace United States 19 459 0.7× 618 1.1× 362 1.2× 307 1.4× 179 0.8× 30 1.7k
Bret M. Benton United States 18 590 1.0× 677 1.2× 338 1.1× 262 1.2× 95 0.4× 25 1.3k
Simona Pollini Italy 25 756 1.2× 493 0.9× 225 0.8× 877 3.9× 147 0.7× 45 2.0k
Susan M. Seo United States 21 926 1.5× 991 1.8× 334 1.1× 779 3.4× 261 1.2× 28 1.9k
A. Simon Lynch United States 19 605 1.0× 366 0.7× 300 1.0× 518 2.3× 167 0.8× 29 1.4k
Sandrine Lemaire Belgium 23 509 0.8× 766 1.4× 406 1.4× 464 2.0× 87 0.4× 43 1.5k
Paul Majcherczyk Switzerland 24 616 1.0× 652 1.2× 248 0.8× 213 0.9× 52 0.2× 37 1.6k
Matthias Willmann Germany 19 785 1.3× 342 0.6× 239 0.8× 562 2.5× 55 0.3× 41 1.8k
Jamese J. Hilliard United States 19 675 1.1× 491 0.9× 128 0.4× 250 1.1× 172 0.8× 37 1.4k
Saeed Khoshnood Iran 23 601 1.0× 628 1.1× 149 0.5× 390 1.7× 87 0.4× 96 1.8k

Countries citing papers authored by Dmitri Debabov

Since Specialization
Citations

This map shows the geographic impact of Dmitri Debabov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitri Debabov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitri Debabov more than expected).

Fields of papers citing papers by Dmitri Debabov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitri Debabov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitri Debabov. The network helps show where Dmitri Debabov may publish in the future.

Co-authorship network of co-authors of Dmitri Debabov

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitri Debabov. A scholar is included among the top collaborators of Dmitri Debabov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitri Debabov. Dmitri Debabov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Zeng, Daina, Dmitri Debabov, Theresa L. Hartsell, et al.. (2016). Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance. Cold Spring Harbor Perspectives in Medicine. 6(12). a026989–a026989. 143 indexed citations
5.
6.
Rani, Suriani Abdul, et al.. (2014). The In Vitro Antimicrobial Activity of Wound and Skin Cleansers at Nontoxic Concentrations. Advances in Skin & Wound Care. 27(2). 65–69. 29 indexed citations
7.
Francavilla, Charles, Donogh J. R. O’Mahony, Lisa Friedman, et al.. (2013). Sulfonyl-polyol N,N-dichloroamines with rapid, broad-spectrum antimicrobial activity. Bioorganic & Medicinal Chemistry Letters. 23(20). 5650–5653. 4 indexed citations
8.
Jekle, Andreas, Suriani Abdul Rani, Chris Celeri, et al.. (2013). Broad-Spectrum Virucidal Activity of (NVC-422)N,N-dichloro-2,2-dimethyltaurine against Viral Ocular Pathogens In Vitro. Investigative Ophthalmology & Visual Science. 54(2). 1244–1244. 4 indexed citations
9.
Gottardi, Waldemar, Dmitri Debabov, & Markus Nagl. (2013). N -Chloramines, a Promising Class of Well-Tolerated Topical Anti-Infectives. Antimicrobial Agents and Chemotherapy. 57(3). 1107–1114. 83 indexed citations
10.
Ehrlenbach, Silvia, Herbert Lindner, Leopold Kremser, et al.. (2012). N-Chlorotaurine, a Long-Lived Oxidant Produced by Human Leukocytes, Inactivates Shiga Toxin of Enterohemorrhagic Escherichia coli. PLoS ONE. 7(11). e47105–e47105. 16 indexed citations
11.
12.
Singhal, Deepti, Andreas Jekle, Dmitri Debabov, et al.. (2012). Efficacy of NVC‐422 against Staphylococcus aureus biofilms in a sheep biofilm model of sinusitis. International Forum of Allergy & Rhinology. 2(4). 309–315. 16 indexed citations
13.
Jekle, Andreas, Meghan Zuck, Ramin Najafi, et al.. (2012). NVC-422 Inactivates Staphylococcus aureus Toxins. Antimicrobial Agents and Chemotherapy. 57(2). 924–929. 11 indexed citations
14.
Hammerer‐Lercher, Angelika, Meghan Zuck, Andreas Jekle, et al.. (2012). Antimicrobial and Anticoagulant Activities of N -Chlorotaurine, N , N -Dichloro-2,2-Dimethyltaurine, and N -Monochloro-2,2-Dimethyltaurine in Human Blood. Antimicrobial Agents and Chemotherapy. 56(4). 1979–1984. 20 indexed citations
15.
Jekle, Andreas, Ramin Najafi, Meghan Zuck, et al.. (2011). Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis. Antiviral Research. 92(3). 470–478. 19 indexed citations
16.
Wang, Lu, Barbara Belisle, Mansour Bassiri, et al.. (2011). Chemical Characterization and Biological Properties of NVC-422, a Novel, Stable N -Chlorotaurine Analog. Antimicrobial Agents and Chemotherapy. 55(6). 2688–2692. 24 indexed citations
17.
Francavilla, Charles, et al.. (2009). Quaternary ammonium N,N-dichloroamines as topical, antimicrobial agents. Bioorganic & Medicinal Chemistry Letters. 19(10). 2731–2734. 21 indexed citations
18.
Clemans, Daniel L., Paul E. Kolenbrander, Dmitri Debabov, et al.. (1999). Insertional Inactivation of Genes Responsible for the d -Alanylation of Lipoteichoic Acid in Streptococcus gordonii DL1 (Challis) Affects Intrageneric Coaggregations. Infection and Immunity. 67(5). 2464–2474. 48 indexed citations
19.
Neuhaus, Francis C., Michael P. Heaton, Dmitri Debabov, & Qunying Zhang. (1996). The dlt Operon in the Biosynthesis of d -Alanyl-Lipoteichoic Acid in Lactobacillus casei. Microbial Drug Resistance. 2(1). 77–84. 58 indexed citations
20.
Debabov, Dmitri, et al.. (1996). The D-Alanyl carrier protein in Lactobacillus casei: cloning, sequencing, and expression of dltC. Journal of Bacteriology. 178(13). 3869–3876. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Pace Breakdown of academic impact, for papers by Bret M. Benton Breakdown of academic impact, for papers by Simona Pollini Breakdown of academic impact, for papers by Susan M. Seo Breakdown of academic impact, for papers by A. Simon Lynch Breakdown of academic impact, for papers by Sandrine Lemaire Breakdown of academic impact, for papers by Paul Majcherczyk Breakdown of academic impact, for papers by Matthias Willmann Breakdown of academic impact, for papers by Jamese J. Hilliard Breakdown of academic impact, for papers by Saeed Khoshnood
Rankless by CCL
2026